AGI-5198,突变体异柠檬酸脱氢酶1(mIDH1)的有效抑制剂

AGI-5198 (订货以英文为准)

编号:A126546
CAS号:1355326-35-0
分子式:C27H31FN4O2
分子量:462.56
货号 品牌 包装 目录价 您的价格 库存 数量 购买
A126546-25mg 阿拉丁 25mg ¥378.90
A126546-5mg 阿拉丁 5mg ¥165.90
A126546-100mg 阿拉丁 100mg ¥968.90
产品名称 AGI-5198
中文名称 AGI-5198,突变体异柠檬酸脱氢酶1(mIDH1)的有效抑制剂
CAS号 1355326-35-0
分子式(M.F.) C27H31FN4O2
分子量(M.W.) 462.56
储存条件 -20°C储存
溶解性DMSO 24 mg/mL Water <1 mg/mL Ethanol 14 mg/mL
存贮条件储存温度-20°C
应用AGI-5198(IDH C35)是剂量依赖的R132H-IDH1抑制剂
产品介绍AGI-5198 is the first highly potent and selective inhibitor of IDH1 R132H/R132C mutants with IC50 of 0.07 μM/0.16 μM.
备注AGI-5198 is the first highly potent and selective inhibitor of IDH1 R132H/R132C mutants with IC50 of 0.07 μM/0.16 μM.
生化机理Description:IC50 Value: N/AAGI-5198, a novel R132H-IDH1 inhibitor, identified through a high-throughput screen blocked, in a dose-dependent manner, the ability of the mutant enzyme (mIDH1) to produce R-2-hydroxyglutarate (R-2HG). The recent discovery of mutations in metabolic enzymes has rekindled interest in harnessing the altered metabolism of cancer cells for cancer therapy. Isocitrate dehydrogenase 1 (IDH1) is one potential drug target, which is mutated in multiple human cancers [1].in vitro: N/Ain vivo: N/AClinical trial: N/A
别名;IDH-C35;AGI5198;AGI 5198;IDH C35;N-Cycohexyl-2-(N-(3-fluorophenyl)-2-(2-methyl-1H-imidazol-1-yl)acetamido)-2-(o-tolyl)acetamide; N-[2-(Cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl]-N-(3-fluorophenyl)-2-methyl-1H-imidazole-1-acetamide
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:19455-79-9
¥ 688.00 C909708-25g
¥ 400.00 SBJ-RBC-S004-100ml
¥ 1150.00 A0357-50μl
¥ 1150.00 A5431-50μl
¥ 825.00 SF-150-1箱
CAS号:27519-02-4
¥ 268.00 T-63624+1ml
CAS号:13389-42-9
¥ 232.00 M68521-1ML
CAS号:14919-01-8
¥ 251.00 M68518-1ML